These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 12015922)
1. [The Ravel trial. Zero percent restenosis: A cardiologists dream comes true!]. Regar E; Serruys PW Rev Esp Cardiol; 2002 May; 55(5):459-62. PubMed ID: 12015922 [No Abstract] [Full Text] [Related]
2. Stenting for small coronary vessels: a contestable winner. Kastrati A; Schühlen H; Schömig A J Am Coll Cardiol; 2001 Nov; 38(6):1604-7. PubMed ID: 11704370 [No Abstract] [Full Text] [Related]
3. [Drug-eluting stents do they make the difference? ]. Presbitero P; Asioli M Minerva Cardioangiol; 2002 Oct; 50(5):431-42. PubMed ID: 12384625 [TBL] [Abstract][Full Text] [Related]
5. Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size. Regar E; Serruys PW; Bode C; Holubarsch C; Guermonprez JL; Wijns W; Bartorelli A; Constantini C; Degertekin M; Tanabe K; Disco C; Wuelfert E; Morice MC; Circulation; 2002 Oct; 106(15):1949-56. PubMed ID: 12370218 [TBL] [Abstract][Full Text] [Related]
6. Drug-eluting stenting for unprotected left main coronary artery disease: are we ready to replace bypass surgery? Baim DS; Mauri L; Cutlip DC J Am Coll Cardiol; 2006 Feb; 47(4):878-81. PubMed ID: 16487859 [No Abstract] [Full Text] [Related]
7. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A; JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543 [TBL] [Abstract][Full Text] [Related]
9. [Drug-eluting stents: do they keep their promises?]. Nordmann A Praxis (Bern 1994); 2006 Apr; 95(15):581-3. PubMed ID: 16640178 [No Abstract] [Full Text] [Related]
10. Coronary balloon angioplasty, stents, and scaffolds. Byrne RA; Stone GW; Ormiston J; Kastrati A Lancet; 2017 Aug; 390(10096):781-792. PubMed ID: 28831994 [TBL] [Abstract][Full Text] [Related]
11. Through the drug-eluting stent labyrinth. Guagliumi G; Musumeci G; Vassileva A; Tespili M; Valsecchi O Ital Heart J; 2003 Apr; 4(4):236-45. PubMed ID: 12784776 [TBL] [Abstract][Full Text] [Related]
12. A paclitaxel-eluting stent for the prevention of coronary restenosis. Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373 [TBL] [Abstract][Full Text] [Related]
13. Are drug-eluting stents the preferred treatment for multivessel coronary artery disease? Klein LW J Am Coll Cardiol; 2006 Jan; 47(1):22-6. PubMed ID: 16386659 [TBL] [Abstract][Full Text] [Related]
14. Why the provisional single-stent approach is not always the right strategy; arguments for the development of dedicated bifurcation devices. Grundeken MJ; Stella PR; Wykrzykowska JJ EuroIntervention; 2012 Mar; 7(11):1249-53. PubMed ID: 22433188 [No Abstract] [Full Text] [Related]
17. [When are drug-eluting stents effective? A critical analysis of the presently available data]. Silber S Z Kardiol; 2004 Sep; 93(9):649-63. PubMed ID: 15365732 [TBL] [Abstract][Full Text] [Related]